Lineage Cell Price to Sales vs. Price to Book

BTX Stock  ILS 386.80  24.80  6.03%   
Taking into consideration Lineage Cell's profitability measurements, Lineage Cell Therapeutics may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in June. Profitability indicators assess Lineage Cell's ability to earn profits and add value for shareholders.
For Lineage Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lineage Cell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lineage Cell Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lineage Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lineage Cell Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Lineage Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lineage Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lineage Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lineage Cell Therapeutics Price to Book vs. Price to Sales Fundamental Analysis

Lineage Price to Book vs. Price to Sales

Lineage Cell

 = 
null

Lineage Cell

 = 
null

Use Lineage Cell in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lineage Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will appreciate offsetting losses from the drop in the long position's value.

Lineage Cell Pair Trading

Lineage Cell Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Lineage Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lineage Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lineage Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lineage Cell Therapeutics to buy it.
The correlation of Lineage Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lineage Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lineage Cell Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lineage Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Lineage Cell position

In addition to having Lineage Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Lineage Cell Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lineage Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lineage Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lineage Cell Therapeutics Stock:
Check out Trending Equities.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Lineage Stock analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
To fully project Lineage Cell's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Lineage Cell Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Lineage Cell's income statement, its balance sheet, and the statement of cash flows.
Potential Lineage Cell investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Lineage Cell investors may work on each financial statement separately, they are all related. The changes in Lineage Cell's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lineage Cell's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.